MedPath

DEEPECHO

🇲🇦Morocco
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.

Completed
Conditions
Fetal Growth Restriction
Small for Gestational Age Infant
Oligohydramnios
Polyhydramnios
First Posted Date
2021-09-28
Last Posted Date
2022-07-27
Lead Sponsor
Deepecho
Target Recruit Count
122
Registration Number
NCT05059093
Locations
🇲🇦

Centre de Radiologie Abou Madi, Casablanca, Morocco

🇲🇦

Centre Hospitalier Cheikh Khalifa, Casablanca, Morocco

🇲🇦

Centre Hospitalier Universitaire Ibn Rochd, Casablanca, Morocco

and more 3 locations

News

DeepEcho Receives FDA 510(k) Clearance for AI-Powered Fetal Ultrasound Analysis Platform

The US Food and Drug Administration has granted 510(k) clearance to DeepEcho's AI-powered fetal ultrasound analysis platform, marking a significant milestone in prenatal care technology.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.